{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:55:06Z","timestamp":1777974906717,"version":"3.51.4"},"reference-count":19,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p>Polyethylene glycol\u2010conjugated adenosine deaminase (pegademase) is used for enzyme replacement therapy for patients with severe combined immunodeficiency caused by adenosine deaminase deficiency. The entrapment of pegademase within human energy\u2010replete carrier erythrocytes using a hypo\u2010osmotic dialysis procedure was investigated with the objective of prolonging the <jats:italic>in vivo<\/jats:italic> circulatory half\u2010life of the enzyme and maintaining therapeutic blood levels. Native unmodified adenosine deaminase (ADA) was similarly studied. The efficiency of pegademase entrapment was low (9%) whereas the entrapment of native unmodified ADA was substantial (50%), suggesting that the polyethylene glycol side\u2010chains were impeding intracellular entrapment. The biochemical characteristics and the osmotic fragility of these carrier erythrocytes were not adversely affected by the entrapment of either pegademase or native ADA. <jats:italic>In vivo<\/jats:italic> survival studies of pegademase\u2010loaded <jats:sup>51<\/jats:sup>Cr\u2010labelled carrier erythrocytes in an ADA\u2010deficient adult patient showed a mean cell half\u2010life of 16\u2003d. Carrier erythrocyte\u2010entrapped pegademase and native ADA had <jats:italic>in vivo<\/jats:italic> half\u2010lives of 20 and 12\u00b75\u2003d, respectively, demonstrating that entrapment prolongs the half\u2010life over that of plasma pegademase, which has a circulating half\u2010life of 3\u20136\u2003d. These results provide the basis for a more extensive clinical evaluation of carrier erythrocyte\u2010entrapped native adenosine deaminase therapy.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.02059.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:24:24Z","timestamp":1047363864000},"page":"549-554","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["<i>In vitro<\/i> and <i>in vivo<\/i> studies with human carrier erythrocytes loaded with polyethylene glycol\u2010conjugated and native adenosine deaminase"],"prefix":"10.1111","volume":"109","author":[{"given":"B. E.","family":"Bax","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Bain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. D.","family":"Fairbanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D. B.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs092003P"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1042\/bst024442s"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs094007Pb"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/cs0960171","article-title":"Survival of human carrier erythrocytes in vivo","volume":"96","author":"Bax B.E.","year":"1999","journal-title":"Clinical Science"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902183400703"},{"key":"e_1_2_6_7_2","first-page":"15","article-title":"Comparison and potential of hypo\u2010osmotic and iso\u2010osmotic erythrocyte ghosts and carrier erythrocytes as drug and enzyme carriers","volume":"51","author":"Chalmers R.A.","year":"1985","journal-title":"Bibliotheca Haematologica"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1964.tb14213.x"},{"key":"e_1_2_6_9_2","first-page":"649","article-title":"Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol","volume":"46","author":"Davis S.","year":"1981","journal-title":"Clinical and Experimental Immunology"},{"key":"e_1_2_6_10_2","first-page":"249","article-title":"The uses and properties of PEG\u2010linked proteins","volume":"9","author":"Delgado C.","year":"1992","journal-title":"Critical Reviews in Therapeutic Drug Carrier Systems"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92348-L"},{"key":"e_1_2_6_12_2","first-page":"3646","article-title":"Long\u2010term immune reconstitution and outcome after HLA\u2010nonidentical T\u2010cell\u2010depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients","volume":"91","author":"Haddad E.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_13_2","first-page":"291","article-title":"Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy","volume":"35","author":"Hershfield M.S.","year":"1998","journal-title":"Seminars in Hematology"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109367"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198703053161005"},{"key":"e_1_2_6_16_2","first-page":"330","volume-title":"Advances in the Treatment of Inborn Errors of Metabolism","author":"Hubbard A.R.","year":"1982"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0798-775"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS19980378"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0940207"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90910-9"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02059.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02059.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.02059.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:26:45Z","timestamp":1698578805000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.02059.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1365-2141.2000.02059.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02059.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}